HIDRADENITIS

Clinical trials for HIDRADENITIS explained in plain language.

Never miss a new study

Get alerted when new HIDRADENITIS trials appear

Sign up with your email to follow new studies for HIDRADENITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Terminated 2

Can anifrolumab calm the painful boils of HS? a new trial seeks answers.

Disease control Ongoing

This study tests whether anifrolumab, an antibody drug, can reduce skin abscesses and nodules in people with hidradenitis suppurativa (HS). Fifteen adults with moderate-to-severe HS will receive the drug intravenously over 24 weeks. The main goal is to see if at least half of par…

Matched conditions: HIDRADENITIS

Phase: PHASE2 • Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control

Last updated Jun 27, 2026 09:06 UTC

HIDRADENITIS

Get alerted when new HIDRADENITIS trials appear

Can anifrolumab calm the painful boils of HS? a new trial seeks answers.